New era of personalised epilepsy management

The trial and error approach to epilepsy treatment has not changed for over a century but machine learning and patient derived stem cells promise a personalised and more effective strategy, argue Patrick Kwan and colleagues

Detalles Bibliográficos
Autores principales: Chen, Zhibin, Rollo, Ben, Antonic-Baker, Ana, Anderson, Alison, Ma, Yuanlin, O’Brien, Terence J, Ge, Zongyuan, Wang, Xuefeng, Kwan, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2020
Materias:
Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541035/
https://www.ncbi.nlm.nih.gov/pubmed/33037001
http://dx.doi.org/10.1136/bmj.m3658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541035/
https://www.ncbi.nlm.nih.gov/pubmed/33037001
http://dx.doi.org/10.1136/bmj.m3658

Ejemplares similares